You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study

Article info

Article menu
Research
Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study

Authors

  • Susanna C Larsson Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Department of Surgical Sciences, Uppsala University, Uppsala, Sweden PubMed articlesGoogle scholar articles
  • Benjamin Woolf School of Psychological Science, University of Bristol, Bristol, UK Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, UK PubMed articlesGoogle scholar articles
  • Dipender Gill Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK Chief Scientific Advisor Office, Research and Early Development, Novo Nordisk, Copenhagen, Denmark PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Susanna C Larsson, Karolinska Institutet, Stockholm, 171 77, Sweden; susanna.larsson{at}ki.se
View Full Text

Citation

Larsson SC, Woolf B, Gill D
Appraisal of the causal effect of plasma caffeine on adiposity, type 2 diabetes, and cardiovascular disease: two sample mendelian randomisation study
BMJ Medicine 2023;2:e000335. doi: 10.1136/bmjmed-2022-000335

Publication history

  • Received August 1, 2022
  • Accepted January 18, 2023
  • First published March 14, 2023.
Online issue publication 
March 14, 2023
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.